Published in Hospital and Nursing Home Week, July 12th, 2007
This trend article about University of Toronto, Canada, is an immediate alert from NewsRx to identify developing directions of research.
Study 1: A new study, "Pilot study of safety and tolerability of inhaled hypertonic saline in infants with cystic fibrosis," is now available. According to a study from Toronto, Canada, "Inhaled hypertonic saline (HS) positively affects both lung function and pulmonary exacerbations in children and adults with cystic fibrosis (CF). Early initiation of treatment may potentially reduce lung function decline and improve outcome of CF patients."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital and Nursing Home Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.